Operative Results and Perioperative Morbidity After Intensified Neoadjuvant Chemotherapy with FLOT for Gastroesophageal Adenocarcinoma Impact of Intensified Neoadjuvant Treatment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Operative Results and Perioperative Morbidity After Intensified Neoadjuvant Chemotherapy with FLOT for Gastroesophageal Adenocarcinoma Impact of Intensified Neoadjuvant Treatment
Authors
Keywords
-
Journal
JOURNAL OF GASTROINTESTINAL SURGERY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-11
DOI
10.1007/s11605-019-04511-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501)
- (2019) Masanori Terashima et al. Gastric Cancer
- The Effect of Neoadjuvant Chemoradiation on Anastomotic Leak and Additional 30-Day Morbidity and Mortality in Patients Undergoing Total Gastrectomy for Gastric Cancer
- (2017) Ivy N. Haskins et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Lymph-Node Ratio Classification Strongly Correlates with Cancer Survivals of Patients Who Underwent R0 Resection for Gastric Cancer with More than 15 Nodes Harvested
- (2017) Laura Lorenzon et al. EUROPEAN SURGICAL RESEARCH
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) E. C. Smyth et al. ANNALS OF ONCOLOGY
- Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) F. Lordick et al. ANNALS OF ONCOLOGY
- Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial
- (2016) Salah-Eddin Al-Batran et al. LANCET ONCOLOGY
- Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma
- (2015) Christoph Springfeld et al. ANNALS OF SURGICAL ONCOLOGY
- NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors
- (2015) Christoph Schulz et al. INTERNATIONAL JOURNAL OF CANCER
- Comparative Investigation of Postoperative Complications in Patients With Gastroesophageal Junction Cancer Treated With Preoperative Chemotherapy or Surgery Alone
- (2015) M. P. Achiam et al. Scandinavian Journal of Surgery
- Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers
- (2014) K. Kumagai et al. BRITISH JOURNAL OF SURGERY
- Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database
- (2014) Edmund K. Bartlett et al. SURGERY
- Lymph Node Ratio Is an Independent Prognostic Factor in Gastric Cancer After Curative Resection (R0) Regardless of the Examined Number of Lymph Nodes
- (2012) Alatengbaolide et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)†
- (2012) P. C. Thuss-Patience et al. ANNALS OF ONCOLOGY
- Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial
- (2011) L. E. Ferri et al. ANNALS OF ONCOLOGY
- Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
- (2011) Marc Ychou et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954
- (2010) Christoph Schuhmacher et al. JOURNAL OF CLINICAL ONCOLOGY
- Surgical Factors Influencing Outcomes in Patients Resected for Cancer of the Esophagus or Gastric Cardia
- (2008) Martin Sundelöf et al. WORLD JOURNAL OF SURGERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started